Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Capital Expenditure Over TimeContracting
Percentile Rank33
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$-1.57M
↑ 50% vs avg
Percentile
P33
Within normal range
Streak
3 yr
Consecutive declineContracting
Average
$-3.13M
Historical baseline
PeriodValueYoY Change
TTM$-1.57M-466.1%
2024$-277000.00-113.1%
2023$-130000.00-23.8%
2022$-105000.00+99.5%
2021$-20.41M-7113.8%
2020$-283000.00+91.2%
2019$-3.20M+39.5%
2018$-5.29M-7566.7%
2017$-69000.00-2200.0%
2016$-3000.00-